View in EDS

First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).

Saved in:
Bibliographic Details
Title: First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
Authors: Kurihara H; Diagnostic and Interventional Radiology, Kanagawa Cancer Center Hospital, Yokohama, Japan. Electronic address: kurihara.0420j@kanagawa-pho.jp., Narita Y; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan., Ito K; Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan., Sato H; Neurosurgery, Kanagawa Cancer Center Hospital, Yokohama, Japan., Miyakita Y; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan., Takahashi M; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan., Ohno M; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan., Yanagisawa S; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan., Okita NT; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Sadachi R; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Machida R; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Tateishi K; Neurosurgery, Yokohama City University, Yokohama, Japan., Yoshii Y; LinqMed Inc., Tokyo, Japan. Electronic address: yoshii.yukie@linqmed.co.jp., Waki A; National Institutes for Quantum Science and Technology, Chiba, Japan., Hashimoto H; National Institutes for Quantum Science and Technology, Chiba, Japan., Suzuki H; National Institutes for Quantum Science and Technology, Chiba, Japan., Zhang MR; National Institutes for Quantum Science and Technology, Chiba, Japan., Kawamura K; National Institutes for Quantum Science and Technology, Chiba, Japan., Honda N; Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Yoshimoto M; Exploratory Oncology Research & Clinical Trial Center, National Cancer Center East, Chiba, Japan., Matsumoto H; Isotope Science Center, The University of Tokyo, Tokyo, Japan.
Source: ESMO open [ESMO Open] 2026 Jul 10; Vol. 11 (8), pp. 108249. Date of Electronic Publication: 2026 Jul 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42431136
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First-in-human phase I study of hypoxia-targeting <superscript>64</superscript>Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kurihara+H%22">Kurihara H</searchLink>; Diagnostic and Interventional Radiology, Kanagawa Cancer Center Hospital, Yokohama, Japan. Electronic address: kurihara.0420j@kanagawa-pho.jp.<br /><searchLink fieldCode="AU" term="%22Narita+Y%22">Narita Y</searchLink>; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ito+K%22">Ito K</searchLink>; Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+H%22">Sato H</searchLink>; Neurosurgery, Kanagawa Cancer Center Hospital, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Miyakita+Y%22">Miyakita Y</searchLink>; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+M%22">Takahashi M</searchLink>; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohno+M%22">Ohno M</searchLink>; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yanagisawa+S%22">Yanagisawa S</searchLink>; Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Okita+NT%22">Okita NT</searchLink>; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sadachi+R%22">Sadachi R</searchLink>; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Machida+R%22">Machida R</searchLink>; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tateishi+K%22">Tateishi K</searchLink>; Neurosurgery, Yokohama City University, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshii+Y%22">Yoshii Y</searchLink>; LinqMed Inc., Tokyo, Japan. Electronic address: yoshii.yukie@linqmed.co.jp.<br /><searchLink fieldCode="AU" term="%22Waki+A%22">Waki A</searchLink>; National Institutes for Quantum Science and Technology, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Hashimoto+H%22">Hashimoto H</searchLink>; National Institutes for Quantum Science and Technology, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+H%22">Suzuki H</searchLink>; National Institutes for Quantum Science and Technology, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Zhang+MR%22">Zhang MR</searchLink>; National Institutes for Quantum Science and Technology, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Kawamura+K%22">Kawamura K</searchLink>; National Institutes for Quantum Science and Technology, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Honda+N%22">Honda N</searchLink>; Pharmacy, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimoto+M%22">Yoshimoto M</searchLink>; Exploratory Oncology Research & Clinical Trial Center, National Cancer Center East, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+H%22">Matsumoto H</searchLink>; Isotope Science Center, The University of Tokyo, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2026 Jul 10; Vol. 11 (8), pp. 108249. <i>Date of Electronic Publication: </i>2026 Jul 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42431136
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2026.108249
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108249
    Titles:
      – TitleFull: First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kurihara H
      – PersonEntity:
          Name:
            NameFull: Narita Y
      – PersonEntity:
          Name:
            NameFull: Ito K
      – PersonEntity:
          Name:
            NameFull: Sato H
      – PersonEntity:
          Name:
            NameFull: Miyakita Y
      – PersonEntity:
          Name:
            NameFull: Takahashi M
      – PersonEntity:
          Name:
            NameFull: Ohno M
      – PersonEntity:
          Name:
            NameFull: Yanagisawa S
      – PersonEntity:
          Name:
            NameFull: Okita NT
      – PersonEntity:
          Name:
            NameFull: Sadachi R
      – PersonEntity:
          Name:
            NameFull: Machida R
      – PersonEntity:
          Name:
            NameFull: Tateishi K
      – PersonEntity:
          Name:
            NameFull: Yoshii Y
      – PersonEntity:
          Name:
            NameFull: Waki A
      – PersonEntity:
          Name:
            NameFull: Hashimoto H
      – PersonEntity:
          Name:
            NameFull: Suzuki H
      – PersonEntity:
          Name:
            NameFull: Zhang MR
      – PersonEntity:
          Name:
            NameFull: Kawamura K
      – PersonEntity:
          Name:
            NameFull: Honda N
      – PersonEntity:
          Name:
            NameFull: Yoshimoto M
      – PersonEntity:
          Name:
            NameFull: Matsumoto H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2026 Jul 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1